Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis

Non-alcoholic fatty liver disease (NAFLD) is becoming one of the world's most common chronic liver diseases in childhood, yet no therapy is available that has been approved by the food and drug administration (FDA). Previous studies have reported that telomere and telomerase are involved the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Tingting, Yang, Xingxin, Zhou, Hongping, Xi, Jianjun, Sun, Jingjing, Ke, Yunling, Zhang, Jiankang, Shao, Yidan, Jiang, Xiaojie, Pan, Xuwang, Liu, Shourong, Zhuang, Rangxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764245/
https://www.ncbi.nlm.nih.gov/pubmed/29324774
http://dx.doi.org/10.1371/journal.pone.0189856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764245/
https://www.ncbi.nlm.nih.gov/pubmed/29324774
http://dx.doi.org/10.1371/journal.pone.0189856

Ejemplares similares